Paul T. Henderson

3.2k citations

70 papers · 2.6k indexed · h-index 28

Co-authors: John M. Essigmann Gary B. Schuster Denise R. Jones Gregory K. Hampikian Yongzhi Kan James C. Delaney Sang Soo Hah Steven R. Tannenbaum
Topics: DNA Repair Mechanisms (22 papers)DNA and Nucleic Acid Chemistry (21 papers)Metal complexes synthesis and properties (11 papers)
Cited by: Molecular Biology Cancer Research Physical and Theoretical Chemistry
Journals: Proceedings of the National Academy of Sciences Journal of the American Chemical Society Nucleic Acids Research
Partner nations: United States China Australia

In The Last Decade

Paul T. Henderson

70 papers receiving 2.5k citations

Peers

Countries citing papers authored by Paul T. Henderson

Since Specialization

Citations

This map shows the geographic impact of Paul T. Henderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul T. Henderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul T. Henderson more than expected).

Fields of papers citing papers by Paul T. Henderson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul T. Henderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul T. Henderson. The network helps show where Paul T. Henderson may publish in the future.

Co-authorship network of co-authors of Paul T. Henderson

This figure shows the co-authorship network connecting the top 25 collaborators of Paul T. Henderson. A scholar is included among the top collaborators of Paul T. Henderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul T. Henderson. Paul T. Henderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oxaliplatin–DNA Adducts as Predictive Biomarkers of FOLFOX Response in Colorectal Cancer: A Potential Treatment Optimization Strategy 2020 ·Molecular Cancer Therapeutics ·Maike Zimmermann,Tao Li,Thomas J. Semrad,Chun‐Yi Wu,Ai‐Ming Yu,George D. Cimino,Michael Malfatti,Kurt Haack,Kenneth W. Turteltaub,Chong‐Xian Pan,May Cho,Edward Kim,Paul T. Henderson	20
2	Radiocarbon Tracers in Toxicology and Medicine: Recent Advances in Technology and Science 2019 ·Toxics ·Michael Malfatti,Bruce A. Buchholz,Heather A. Enright,Benjamin J. Stewart,Ted Ognibene,(unknown),Gabriela G. Loots,Maike Zimmermann,(unknown),George D. Cimino,Brian A. Jonas,Chong‐Xian Pan,Graham Bench,Paul T. Henderson,Kenneth W. Turteltaub	7
3	PDX validation of a 3D microtumor platform. 2019 ·Journal of Clinical Oncology ·(unknown),(unknown),Paul T. Henderson,Christian Apfel,Chong-xian Pan,Maike Zimmermann,Ai‐Hong Ma	1
4	COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin 2017 ·Molecular Cancer Therapeutics ·Fuli Wang,Hongyong Zhang,Ai-Hong Ma,Weimin Yu,Maike Zimmermann,Jun Yang,Sung Hee Hwang,Daniel Zhu,(unknown),Michael Malfatti,Kenneth W. Turteltaub,Paul T. Henderson,Susan Airhart,Bruce D. Hammock,Jianlin Yuan,Ralph W. de Vere White,Chong‐Xian Pan	32
5	The Phosphatidylinositol 3-Kinase Pathway as a Potential Therapeutic Target in Bladder Cancer 2017 ·Clinical Cancer Research ·Shuxiong Zeng,Yanjun Zhu,Ai-Hong Ma,Weimin Yu,Hongyong Zhang,Tzu‐yin Lin,Wei Shi,Clifford G. Tepper,Paul T. Henderson,Susan Airhart,(unknown),(unknown),Ralph W. deVere White,Chong-xian Pan	44
6	Synthesis and biochemical characterization of EGF receptor in a water-soluble membrane model system 2017 ·PLoS ONE ·(unknown),Wei He,(unknown),Alexey Tomilov,(unknown),Gino Cortopassi,Kermit L. Carraway,Matthew A. Coleman,Paul T. Henderson	4
7	Microdose-Induced Drug–DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and Mice 2016 ·Molecular Cancer Therapeutics ·Maike Zimmermann,(unknown),Hongyong Zhang,(unknown),Michael Malfatti,Kurt Haack,Ted Ognibene,Hongyuan Yang,Susan Airhart,Kenneth W. Turteltaub,George D. Cimino,Clifford G. Tepper,Alexandra Drakaki,Karim Chamie,Ralph de Vere White,Chong‐Xian Pan,Paul T. Henderson	22
8	Diagnostic Microdosing Approach to Study Gemcitabine Resistance 2016 ·Chemical Research in Toxicology ·(unknown),Hongyong Zhang,Maike Zimmermann,Sisi Wang,Michael Malfatti,George D. Cimino,Kenneth W. Turteltaub,(unknown),Chong‐Xian Pan,Paul T. Henderson	8
9	Cell-free expression of functional receptor tyrosine kinases 2015 ·Scientific Reports ·Wei He,(unknown),(unknown),(unknown),(unknown),Christina L. Takanishi,Greg L. Hura,John A. Tainer,Kermit L. Carraway,Paul T. Henderson,Matthew A. Coleman	21
10	Biodistribution and pharmacokinetics of a telodendrimer micellar paclitaxel nanoformulation in a mouse xenograft model of ovarian cancer 2012 ·International Journal of Nanomedicine ·Wenwu Xiao,Luo,Juntao Luo,Kit S. Lam,Paul T. Henderson,(unknown),(unknown),Harry Tseng,Douglas J. Rowland,Simon R. Cherry	27
11	Characterization of high-affinity peptides and their feasibility for use in nanotherapeutics targeting leukemia stem cells 2011 ·Nanomedicine Nanotechnology Biology and Medicine ·Hongyong Zhang,Juntao Luo,Yuanpei Li,Paul T. Henderson,Yanchun Wang,Sebastian Wachsmann‐Hogiu,Weixin Zhao,Kit S. Lam,(unknown)	23
12	Salvage of oxidized guanine derivatives in the (2′-deoxy)ribonucleotide pool as source of mutations in DNA 2010 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Paul T. Henderson,Mark D. Evans,Marcus S. Cooke	25
13	Characterizing diffusion dynamics of a membrane protein associated with nanolipoproteins using fluorescence correlation spectroscopy 2010 ·Protein Science ·Tingjuan Gao,Craig Blanchette,Wei He,(unknown),Sonny Ly,Federico Katzen,Wieslaw Kudlicki,Paul T. Henderson,Ted A. Laurence,Thomas Huser,Matthew A. Coleman	25
14	Towards biomarker-dependent individualized chemotherapy: Exploring cell-specific differences in oxaliplatin–DNA adduct distribution using accelerator mass spectrometry 2010 ·Bioorganic & Medicinal Chemistry Letters ·Sang Soo Hah,Paul T. Henderson,Kenneth W. Turteltaub	13
15	Design of a phase 0 microdosing trial for correlation of platinum-induced DNA damage to chemotherapy outcomes 2009 ·Journal of Clinical Oncology ·(unknown),(unknown),Miaoling He,Ralph de Vere White,David R. Gandara,(unknown),Primo N. Lara,Kenneth W. Turteltaub,Paul T. Henderson	1
16	Cell-Free Expression for Nanolipoprotein Particles: Building a High-Throughput Membrane Protein Solubility Platform 2008 ·Methods in molecular biology ·Jenny A. Cappuccio,Angela K. Hinz,Edward A. Kuhn,Julia E. Fletcher,(unknown),Paul T. Henderson,Craig Blanchette,(unknown),Michele Corzett,Richard Law,Joseph B. Pesavento,Brent W. Segelke,Todd Sulchek,Brett A. Chromy,Federico Katzen,Todd C. Peterson,Graham Bench,Wieslaw Kudlicki,Paul D. Hoeprich,Matthew A. Coleman	36
17	Incorporation of extracellular 8-oxodG into DNA and RNA requires purine nucleoside phosphorylase in MCF-7 cells 2007 ·Nucleic Acids Research ·(unknown),(unknown),(unknown),V.L. Schramm,Paul T. Henderson	25
18	In Vivo Bypass Efficiencies and Mutational Signatures of the Guanine Oxidation Products 2-Aminoimidazolone and 5-Guanidino-4-nitroimidazole 2004 ·Journal of Biological Chemistry ·William L. Neeley,James C. Delaney,Paul T. Henderson,John M. Essigmann	56
19	EVALUATION OF MICRODOSING STRATEGIES FOR STUDIES IN PRECLINICAL DRUG DEVELOPMENT: DEMONSTRATION OF LINEAR PHARMACOKINETICS IN DOGS OF A NUCLEOSIDE ANALOG OVER A 50-FOLD DOSE RANGE 2004 ·Drug Metabolism and Disposition ·Punam Sandhu,John S. Vogel,Mark J. Rose,Esther A. Ubick,(unknown),Michael A. Wallace,(unknown),(unknown),Paul T. Henderson,Paul G. Pearson,Thomas A. Baillie	45
20	High-fidelity in vivo replication of DNA base shape mimics without Watson–Crick hydrogen bonds 2003 ·Proceedings of the National Academy of Sciences ·James C. Delaney,Paul T. Henderson,Sandra A. Helquist,Juan Carlos Morales,John M. Essigmann,Eric T. Kool	63

About Paul T. Henderson

Paul T. Henderson is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 70 papers that have together received 2.6k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (22 papers), DNA and Nucleic Acid Chemistry (21 papers) and Metal complexes synthesis and properties (11 papers). The work is most often cited by research in Molecular Biology (1.7k citations), Cancer Research (360 citations) and Physical and Theoretical Chemistry (135 citations). Paul T. Henderson has collaborated with scholars based in United States, China and Australia. Frequent co-authors include John M. Essigmann, Gary B. Schuster, Denise R. Jones, Gregory K. Hampikian, Yongzhi Kan, James C. Delaney, Sang Soo Hah, Steven R. Tannenbaum, William L. Neeley and Kenneth W. Turteltaub. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact